Class III nerve-sparing radical hysterectomy versus standard class III radical hysterectomy: An observational study

Annals of Surgical Oncology

Volumn 18, Issue 12, 2011, Pages 3469-3478

  Ditto, Antonino ^a   Martinelli, Fabio ^a   Mattana, Flavia ^a   Reato, Claudio ^b   Solima, Eugenio ^a   Carcangiu, Marialuisa ^a   Haeusler, Edward ^a   Mariani, Luigi ^a   Raspagliesi, Francesco ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b TREVIGLIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HOSPITAL PATIENT; HUMAN; ILEUS; INTERMETHOD COMPARISON; LUNG EMBOLISM; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MORBIDITY; MULTIMODALITY CANCER THERAPY; NERVE SPARING RADICAL HYSTERECTOMY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; RADICAL HYSTERECTOMY; SEPSIS; THROMBOEMBOLISM; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM STAGING; PELVIS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 83055188434     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1767-3     Document Type: Article

References (31)

1. Meigs JV. Radical hysterectomy with bilateral dissection of pelvic lymph nodes: surgical treatment of cancer of the cervix. New York: Grune & Stratton; 1954.
2. Kobayashi T. Abdominal radical hysterectomy with pelvic lymphadenectomy for cancer of the cervix. Tokyo: Nanzando; 1961. p. 178-87.
3. Fujii S. Anatomic identification of nerve-sparing radical hysterectomy: a step-by-step procedure. Gynecol Oncol. 2008;111(2 Suppl):S33-41.
4. Yabuki Y, Asamoto A, Hoshiba T, et al. Dissection of the cardinal ligament in radical hysterectomy for cervical cancer with emphasis on the lateral ligament. Am J Obstet Gynecol. 1991;164:7-14.
5. Hockel M, Konerding MA, Heussel CP. Liposuction-assisted nerve-sparing extended radical hysterectomy: oncologic rationale, surgical anatomy, and feasibility study. Am J Obstet Gynecol. 1998;178:971-6.
6. Possover M, Stober S, Plaul K, et al. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. Gynecol Oncol. 2000;79:154-7.
7. Trimbos JB, Maas CP, Deruiter MC, et al. A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients. Int J Gynecol Cancer. 2001;11:180-6.
8. Raspagliesi F, Ditto A, Fontanelli R, et al. Nerve-sparing radical hysterectomy: a surgical technique for preserving the autonomic hypogastric nerve. Gynecol Oncol. 2004;93:307-14.
9. Ditto A, Martinelli F, Borreani C, et al. Quality of life and sexual, bladder, and intestinal dysfunctions after class III nerve-sparing and class II radical hysterectomies: a questionnaire-based study. Int J Gynecol Cancer. 2009;19:953-7.
10. Papp Z, Csapo Z, Hupuczi P, et al. Nerve-sparing radical hysterectomy for stage IA2-IIB cervical cancer: 5-year survival of 501 consecutive cases. Eur J Gynaecol Oncol. 2006;27:553-60.
11. Van den Tillaart SA, Kenter GG, Peters AA, et al. Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA. Int J Gynecol Cancer. 2009;19:39-45.
12. Skret-Magierlo J, Naróg M, Kruczek A, et al. Radical hysterectomy during the transition period from traditional to nervesparing technique. Gynecol Oncol. 2010;116:502-5.
13. Ditto A, Martinelli F, Hanozet F, et al. Class III NSRH: oncological outcome in 170 cervical cancer patients. Gynecol Oncol. 2010;119:192-7.
14. Pecorelli S. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103-4.
15. Raspagliesi F, Ditto A, Kusamura S, et al. Nerve-sparing radical hysterectomy: a pilot study. Tumori. 2003;89:497-501.
16. Raspagliesi F, Ditto A, Hanozet F, et al. Nerve sparing radical hysterectomy for the treatment of cervical cancer: new research on surgical techniques. In: Varaj HT, editor. Trends in cervical cancer research. Hauppauge, NY: Nova Science Publishers; 2007. p. 97-123.
17. Korn EL, Dorey FJ. Applications of crude incidence curves. Stat Med. 1992;11:813-29.
18. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-54.
19. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-41.
20. Brucker PS, Yost K, Cashy J, et al. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof. 2005;28:192-211.
21. Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3-12.
22. Girardi F, Lichtenegger W, Tamussino K, et al. The importance of parametrial lymph nodes in the treatment of cervical cancer. Gynecol Oncol. 1989;34:206-11.
23. Benedetti-Panici P, Maneschi F, Scambia G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol. 1996;62:19-24.
24. Raspagliesi F, Ditto A, Hanozet F, et al. Nerve-sparing radical hysterectomy in cervical cancer evolution of concepts. Gynecol Oncol. 2007;107(1 Suppl 1):S119-21.
25. Raspagliesi F, Ditto A, Fontanelli R, et al. Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006;102:256-62.
26. Samlal RA, Van der Velden J, Van Eerden T, et al. Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer. 1998;8:78-84.
27. Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002;20:179-88.
28. Buda A, Fossati R, Colombo N, et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol. 2005;23:4137-45.
29. Lissoni AA, Colombo N, Pellegrino A, et al. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a threedrug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol. 2009;20:660-5.
30. Trimbos JB, Franchi M, Zanaboni F, et al. "State of the art" of radical hysterectomy; current practice in European oncology centres. Eur J Cancer. 2004;40:375-8.
31. Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9:297-303.